SCHEMBL17788239

SCHEMBL17788239

CCc1cccc(C(=O)Cl)c1COc1ccc(C)cc1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 8/20 0.49
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
TP53 P04637 1/20 0.43
HSD17B10 Q99714 1/20 0.43
FFAR4 Q5NUL3 4/20 0.41
FFAR1 O14842 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
POLB P06746 1/20 0.40
PTGER1 P34995 1/20 0.39
PTGER4 P35408 1/20 0.39
PTGER3 P43115 1/20 0.39
PTGER2 P43116 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16920918 0.89 MRGPRX4 (0.56) MRGPRX4NPC1RAB9ATP53HSD17B10
SCHEMBL17788238 0.88 MRGPRX4 (0.52) MRGPRX4NPC1RAB9ATP53HSD17B10
SCHEMBL17788263 0.88 MRGPRX4 (0.52) MRGPRX4NPC1RAB9ATP53HSD17B10
SCHEMBL17788241 0.87 MAPT (0.41) MRGPRX4RAB9ATP53FFAR4FFAR1
SCHEMBL17788318 0.86 MRGPRX4 (0.48) MRGPRX4NPC1RAB9ATP53HSD17B10
SCHEMBL17788290 0.86 MRGPRX4 (0.48) MRGPRX4NPC1RAB9ATP53HSD17B10
SCHEMBL17788240 0.86 MRGPRX4 (0.50) MRGPRX4NPC1RAB9ATP53HSD17B10
SCHEMBL17788245 0.85 MRGPRX4 (0.49) MRGPRX4NPC1RAB9ATP53HSD17B10
SCHEMBL17788254 0.85 MRGPRX4 (0.44) MRGPRX4NPC1RAB9ATP53FFAR4
SCHEMBL17788260 0.85 MRGPRX4 (0.47) MRGPRX4FFAR4FFAR1PTGER1PTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9888688-B2 Tetrazolinone compounds and applications thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-02-13 US disclosed
US-20160150787-A1 TETRAZOLINONE COMPOUNDS AND APPLICATIONS THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160150787-A1 TETRAZOLINONE COMPOUNDS AND APPLICATIONS THEREOF SOD1, UQCRB, MT-CO1 MRGPRX4 2498/4885NPC1 3560/4885RAB9A 533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.